Fibrostatin, S.L.
Records under this name other than the patents Fibrostatin, S.L. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 3 of 3 · Back to Fibrostatin, S.L.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,066,938 | GPBP-1 inhibition and its therapeutic use Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,586,776 | GPBP inhibition using Q2 peptidomimetics Lapsed on the fee record Ended Nov 19, 2025 · From the USPTO record | Lapsed on the fee record | Ended Nov 19, 2025 | From the USPTO record |
| US 10,544,083 | GPBP inhibition using Q2 peptidomimetics Lapsed on the fee record Ended Jan 28, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2024 | From the USPTO record |